Upcoming event

Randomized, double-blind phase III study of pazopanib versus placebo in patients with metastatic renal cell carcinoma who have no evidence of disease following metastasectomy: A trial of the ECOG-ACRIN cancer research group (E2810)

May 2019

Unraveling the molecular profile underpinning pancreatic tropisms in metastatic clear cell renal cell carcinoma

May 2019

Cardiovascular mortality in renal cell carcinoma: A population-based study

May 2019

Stereotactic radiotherapy for stage I renal cell carcinoma: Overall survival and treatment trends compared to thermal ablation and surgical resection

May 2019

Testing the external validity of CARMENA trial comparing sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma

Predicting Functional Outcomes after Partial Nephrectomy

May 2019

Impact of tumor size on cancer specific mortality after local tumor ablation in T1a renal cell carcinoma

Journal of Endourology, April 2019

Clinical utility of the mutational landscape and fragment size of circulating tumor DNA in renal cell carcinoma

March 2019

The role of non-tumour renal biopsy in patients treated with radical nephrectomy

March 2019

Individualized immune-related gene signature predicts immune status and oncologic outcomes in clear cell renal call carcinoma patients

March 2019

Identification of a microRNA profile in urine with diagnostic and prognostic value for clear cell renal cell carcinoma

March 2019

Subgroup analysis from JAVELIN Renal 101: Outcomes for avelumab plus axitinib (A + Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC)

Next